Hologic (HOLX) Tops Q3 EPS by 3c; offers guidance

Hologic (NASDAQ: HOLX) reported Q3 EPS of $1.08, $0.03 better than the analyst estimate of $1.05. Revenue for the quarter came in at $1.02 billion versus the consensus estimate of $1.01 billion.

GUIDANCE:

Hologic sees Q4 2025 EPS of $1.09-$1.12, versus the consensus of $1.07. Hologic sees Q4 2025 revenue of $1.03-1.04 billion, versus the consensus of $1.034 billion.

Hologic sees FY2025 EPS of $4.23-$4.26, versus the consensus of $4.18. Hologic sees FY2025 revenue of $4.081-4.091 billion, versus the consensus of $4.074 billion.

For earnings history and earnings-related data on Hologic (HOLX) click here.

You May Also Be Interested In

• Aggreko files for proposed IPO
• Boeing wins $131B F-15 contract from Department of War
• Tetra Tech EC pays $57M to settle false soil test claims